Randomized controlled trial of concurrent hepatitis A and B vaccination

Military Medicine

Volumn 166, Issue 2, 2001, Pages 95-101

  Bryan, J P ^a   McCardle, P ^a   South Paul, J E ^a   Fogarty, J P ^a   Legters, L J ^a   Perine, P L ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE;

ADULT; ANTIBODY DETECTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS A; HEPATITIS B; HUMAN; HUMAN EXPERIMENT; INFECTION PREVENTION; INJECTION PAIN; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; VACCINATION;

EID: 0035116732     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.1093/milmed/166.2.95     Document Type: Article

References (50)

1. The diverse pattern of hepatitis A epidemiology in the United States: Implications for vaccination strategies
2. A multistate, foodborne outbreak of hepatitis A
3. Multistate outbreak of hepatitis A associated with frozen strawberries
4. Secular trends in hepatitis A virus infection among Alaska natives
5. Hepatitis A
6. Hepatitis A from the military perspective
7. The military and hepatitis B
8. An outbreak of hepatitis A during a military field training exercise
9. Viral hepatitis in the US Navy. 1975-84
10. Hepatitis A and B in a naval population
11. Risk of viral hepatitis among military personnel assigned to US Navy ships
12. Acute viral hepatitis in American soldiers in Korea
13. Viral hepatitis A and B in wounded patients
14. Viral hepatitis in French United Nations military personnel
15. Epidemiology and prevention of hepatitis A in travelers
16. Risk factors for hepatitis A, B and C virus infection among Swedish expatriates
17. The risk of viral hepatitis A, B, C and E among North American missionaries
18. Development of the formalin-inactivated hepatitis A vaccine VAQTA™ from the live attenuated virus strain CR326F
19. Inactivated hepatitis A vaccines
20. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children
21. Protection against hepatitis A by an inactivated vaccine
22. Vaccines to prevent viral hepatitis
23. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination
24. Update: Recommendations to prevent hepatitis B virus transmission, United States
25. Immunizations for international travel
26. Travel medicine: Prevention based on epidemiological data
27. The case for routine childhood vaccination against hepatitis A
28. The first combined vaccine against hepatitis A and B: An overview
29. Sensitive assays for hepatitis A antibodies
30. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men
31. Dose response study of an inactivated hepatitis A virus vaccine
32. Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: An overview
33. Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A
34. Six years' follow-up after hepatitis A vaccination
35. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
36. The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults
37. A dose response study of hepatitis A vaccine in healthy adults who are ≥ 30 years old and weigh ≥ 77 kg
38. Hepatitis A vaccine, purified inactivated
39. Clinical experience with an inactivated hepatitis A vaccine
40. Simultaneous vaccination for hepatitis A and B
41. Simultaneous vaccination against hepatitis A and B: Results of a controlled study
42. Administration of hepatitis A vaccine to a military population by needle and jet injector and with hepatitis B vaccine
43. Reactogenicity and immunogenicity of a combined hepatitis A and B vaccine in healthy adults
44. Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine
45. Safety and immunogenicity of a combined hepatitis A and hepatitis B vaccine in young healthy adults
46. New combined hepatitis A and B vaccine
47. Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine
48. Licensure of inactivated hepatitis A vaccine and recommendations for use among international travelers
49. Immunisation is only part of preventing infectious disease
50. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease